𝔖 Bobbio Scriptorium

✦ LIBER ✦

Triple therapy (aspirin, clopidogrel and oral anticoagulant) after percutaneous coronary intervention: another call for personalized medicine

✍ Scribed by Tanrikulu, Azra; Agirbasli, Mehmet

Book ID: 120389830
Publisher: Kare Publishing
Year: 2013
Tongue: English
Weight: 110 KB
Category: Article
ISSN: 1302-8723
DOI: 10.5152/akd.2013.147

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Use of clopidogrel with or without aspir

Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial

✍ Dewilde, Willem JM; Oirbans, Tom; Verheugt, Freek WA; Kelder, Johannes C; De Sme 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 294 KB

Long-Term Cost Effectiveness of Early an

Long-Term Cost Effectiveness of Early and Sustained Dual Oral Antiplatelet Therapy With Clopidogrel Given for Up to One Year After Percutaneous Coronary Intervention: Results From the Clopidogrel for the Reduction of Events During Observation (CREDO) Trial

✍ S.C. Beinart; P. Kolm; E. Veledar 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 37 KB

Long-Term Cost Effectiveness of Early an

Long-Term Cost Effectiveness of Early and Sustained Dual Oral Antiplatelet Therapy With Clopidogrel Given for Up to One Year After Percutaneous Coronary Intervention: Results From the Clopidogrel for the Reduction of Events During Observation (CREDO) Trial

✍ Sean C. Beinart; Paul Kolm; Emir Veledar; Zefeng Zhang; Elizabeth M. Mahoney; Ol 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 206 KB